REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/02/2025
Back to search
Official data from USPTO
SAXENDACARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
03/03/2025
Trademark type
Word
Nice classes
44
Filing date
01/29/2015
Registration date
03/01/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/21/2022
Last transaction
03/03/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/30/2015
First use in commerce
04/30/2015
Drawing code
4
Owner type
99
Owner location
Bagsværd, DK
Examiner
MITTLER,ROBIN M
Law office
N10
Current location
TMO LAW OFFICE 119
Holders and representatives
Holders
Novo Nordisk A/S
Representatives
Alexander Reid White & Case Llp
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing health and medical information in the field of obesity and obesity management; and providing a website that features health and medical information in the field of obesity and obesity management
Publications
History of USPTO decisions and trademark events.
28 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/21/2022
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
07/21/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/19/2022
ES8R
TEAS SECTION 8 RECEIVED
02/15/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/01/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/01/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/28/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/27/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/25/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/22/2016
IUAF
USE AMENDMENT FILED
12/11/2015
EISU
TEAS STATEMENT OF USE RECEIVED
12/11/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/21/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/26/2015
PUBO
PUBLISHED FOR OPPOSITION
05/26/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/06/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/17/2015
ALIE
ASSIGNED TO LIE
04/14/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/25/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
03/25/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/25/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
03/25/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/25/2015
DOCK
ASSIGNED TO EXAMINER
03/18/2015
MPMK
NOTICE OF PSEUDO MARK E-MAILED
02/10/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/07/2015
NWAP
NEW APPLICATION ENTERED
02/02/2015
Continuous trademark protection
Get notified about every new filing that threatens SAXENDACARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.